Moderna is suing Pfizer and BioNTech, accusing the companies of infringing on Moderna’s patents when they developed their own COVID-19 vaccine.

(HealthDay News) — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

Pfizer (NYSE:PFE) stock is down around 25% from its 52-week high of over $31 to $23 now. Pipeline setbacks, including an experimental treatment for Duchenne muscular dystrophy (DMD) failing in a ...

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

Moderna, Pfizer hit with new patent lawsuits over COVID vaccines. Obesity speeds up loss of immunity from COVID-19 vaccines, new research finds. HHS Secretary Robert F. Kennedy Jr., ...

While Moderna’s shots, as well as Pfizer-BioNTech’s Comirnaty, are mRNA-based, Novavax’s vaccine is protein-based and takes longer to manufacture. Moderna this month withdrew an application ...

Moderna's mRNA-based flu vaccine funding is cancelled by the Department of Health and Human Services, ... the technology that Moderna and Pfizer used to develop their COVID-19 vaccines. ...

Shareholders of PFIZER may learn more about this investigation by contacting Berger Montague: Radha Raghavan at rraghavan@bm.net or (332) 271-8908, or Andrew Abramowitz at aabramowitz@bm.net or ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the ...

Airport screening in the U.S. detected the new variant in travelers arriving in California, Washington state, Virginia and ...